Typ : |
Zeitung |
Internet-Link : |
http://www.cjhp-online.ca/index.php/cjhp/article/view/1579/2386 |
|
Forschungsgruppen : |
Montreal - Faculté de pharmacie, Université de Montréal |
Autoren : |
Friciu M, Zaraa S, Leclair G. |
Titel : |
Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions |
Veröffentlichung : |
Can J Hosp Pharm ; 69, 4: 327-329. 2016 |
|
Niveau von Beweisen : |
|
physikalische Stabilität : |
|
chemische Stabilität : |
|
andere Verfahren : |
|
Kommentare : |
|
Molekülverzeichnis
Amlodipine besylate
|
|
|
|
|
30 mg Norvasc® |
|
23-27°C |
|
60 |
|
|
|
|
|
|
30 mg ® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
60 |
|
|
|
|
|
|
30 mg Norvasc® |
|
3-7°C |
|
90 |
|
|
|
|
|
|
30 mg ® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
90 |
|
|
|
|
|
|
1 mg Norvasc® |
|
23-27°C |
|
45 |
|
|
|
|
|
|
1 mg ® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
45 |
|
|
|
|
|
|
1 mg Norvasc® |
|
3-7°C |
|
90 |
|
|
|
|
|
|
1 mg ® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
90 |
|
|
|
|
|